Introduction of new devices and technologies into a spine surgery practice: A review of processes and regulations

Orthopedics

Volumn 33, Issue 10, 2010, Pages

  Berven, Sigurd H ^a   Yaszemski, Michael J ^b   Newton, Peter O ^c   Christianson, William ^d   Aberman, Harold M ^e   Moreau, Jean Charles ^f   Mulcahey, Mary Jane ^g   Betz, Randal R ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

^d Synthes Technical Center   (United States)

^e Synthes Spine   (United States)

^f Medtronic Sofamor Danek   (United States)

^g SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

CHEMONUCLEOLYSIS; COST EFFECTIVENESS ANALYSIS; DEVICE; ELECTROSTIMULATION THERAPY; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; IMPLANT; INJECTION; MEDICAID; MEDICAL TECHNOLOGY; MEDICARE; NERVE BLOCK; ORTHOPEDIC SURGERY; PATIENT SAFETY; POSTMARKETING SURVEILLANCE; PROSTHESIS; REGISTER; REIMBURSEMENT; REVIEW; SCOLIOSIS; SPINE SURGERY; UNITED KINGDOM; UNITED STATES; CLINICAL TRIAL (TOPIC); DEVICE APPROVAL; FINANCIAL MANAGEMENT; METHODOLOGY; ORTHOPEDIC EQUIPMENT; ORTHOPEDICS; PROSTHESES AND ORTHOSES; SPINE; SURGERY;

CLINICAL TRIALS AS TOPIC; DEVICE APPROVAL; HUMANS; MARKETING OF HEALTH SERVICES; ORTHOPEDIC FIXATION DEVICES; ORTHOPEDICS; PROSTHESES AND IMPLANTS; SPINE; SURGICAL PROCEDURES, OPERATIVE;

EID: 77958014578     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20100826-18     Document Type: Review

References (25)

1. US Food and Drug Administration. PMA Approvals. US Department of Health & Human Services Web site. http://www.fda.gov/medicaldevices/ productsandmedicalprocedures/deviceapprovalsandclearances/pmaapprovals/default. htm. Updated June 18, 2009. Accessed August 24, 2009.
2. Maisel WH. Medical device regulation: an introduction for the practicing physician. Ann Intern Med. 2004; 140(4):296-302.
3. Kaplan AV, Baim DS, Smith JJ, et al. Medical device development: from prototype to regulatory approval. Circulation. 2004; 109(25):3068-3072.
4. Food and Drug Administration, HHS. Orthopedic devices: classification and reclassification of pedicle screw spinal systems; technical amendment. Final rule; technical amendment. Fed Regist. 2001; 66(99):28051-28053.
5. Kirkpatrick JS, Stevens T. The FDA process for the evaluation and approval of orthopaedic devices. J Am Acad Orthop Surg. 2008; 16(5):260-267.
6. Food and Drug Administration, HHS. Orthopedic devices; effective data of requirement for premarket approval for hip joint metal/polymer or ceramic/polymer semiconstrained resurfacing cemented prosthesis. Final rule. Fed Regist. 2004; 69(191):59132-59134.
7. Obremskey WT, Marotta JS, Yaszemski MJ, Churchill LR, Boden SD, Dirschl DR. Symposium. The introduction of biologics in orthopaedics: issues of cost, commercialism, and ethics. J Bone Joint Surg Am. 2007; 89(7):1641-1649.
8. Barnes B, Boden SD, Louis-Ugbo J, et al. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates. Spine (Phila Pa 1976). 2005; 30(10):1127-1133.
9. Dimar JR, Glassman SD, Burkus KJ, Carreon LY. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine (Phila Pa 1976). 2006; 31(22):2534-2539.
10. Mehran R, Leon MB, Feigal DA, et al. Post-market approval surveillance: a call for a more integrated and comprehensive approach. Circulation. 2004; 109(25):3073-3077.
11. Levin JH. Prospective, double-blind, randomized placebo-controlled trials in interventional spine: what the highest quality literature tells us [published online ahead of print September 11, 2008]. Spine J. 2009; 9(8):690-703.
12. Freeman BJ, Fraser RD, Cain CM, Hall DJ, Chapple DC. A randomized, double-blind, controlled trial: intradiscal electrothermal therapy versus placebo for the treatment of chronic discogenic low back pain. Spine (Phila Pa 1976). 2005; 30(21):2369-2377.
13. Korthals-de Bos I, van Tulder M, van Dieten H, Bouter L. Economic evaluations and randomized trials in spinal disorders: principles and methods. Spine (Phila Pa 1976). 2004; 29(4):442-448.
14. Thompson GH, Akbarnia BA, Campbell RM Jr. Growing rod techniques in early-onset scoliosis. J Pediatr Orthop. 2007; 27(3):354-361.
15. Rudicel S, Esdaile J. The randomized clinical trial in orthopaedics: obligation or option? J Bone Joint Surg Am. 1985; 67(8):1284-1293. (Pubitemid 16222977)
16. Patrick J. An overview of the regulatory aspects of medical devices from the viewpoint of research and device manufacturing. Reg Anesth. 1993; 18(6 Suppl):424-427. (Pubitemid 24022578)
17. Chai JY. Medical device regulation in the United States and the European Union: a comparative study. Food Drug Law J. 2000; 55(1):57-80.
18. Bucci VA, Reiss JB, Hall NC. New obstacles in the path of marketing new medical devices. J Health Care Technol. 1985; 2(2):81-96.
19. Medicare payment for new technologies. Can the process be improved despite conflicting goals? An ECRI technology management assessment. J Health Care Technol. 1986; 3(1):13-32.
20. Smith JJ, Henderson JA. Satisfying the requirements of the Food and Drug Administration and Centers for Medicare and Medicaid Services. J Am Coll Radiol. 2008; 5(3):189-192.
21. Hadley J, Reschovsky J, Corey C, Zuckerman S. Medicare fees and the volume of physicians' services. Inquiry. 2010; 46(4):372-390.
22. Yaszemski MJ, Polly DW, Boden SD, Andersson GB. Technology assessment: approach and reimbursement. Spine (Phila Pa 1976). 2007; 32(11 Suppl):S39-43.
23. Feldman MD, Petersen AJ, Karliner LS, Tice JA. Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment. J Gen Intern Med. 2008; 23(Suppl 1):57-63.
24. Berven S, Smith A, Bozic K, Bradford DS. Pay-for-performance: considerations in application to the management of spinal disorders. Spine (Phila Pa 1976). 2007; 32(11 Suppl):S33-38.
25. Donawa M. US and European postmarket clinical data requirements. Med Device Technol. 2005; 16(2):19-21.